List of Deciphera Pharmaceuticals patents

Patents where

Current Assignee

Name

Deciphera Pharmaceuticals

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 8188113 Dihydropyridopyrimidinyl, dihydronaphthyidinyl and related compounds useful as kinase inhibitors for the treatment of proliferative diseases	Patent 8188113 was granted and assigned to Deciphera Pharmaceuticals on May, 2012 by the United States Patent and Trademark Office.		Deciphera Pharmaceuticals	United States Patent and Trademark Office	8188113	May 29, 2012
‌ US Patent 8486951 Cyclopropane amides and analogs exhibiting anti-cancer and anti-proliferative activities	Patent 8486951 was granted and assigned to Deciphera Pharmaceuticals on July, 2013 by the United States Patent and Trademark Office.		Deciphera Pharmaceuticals	United States Patent and Trademark Office	8486951	July 16, 2013
‌ US Patent 8143293 Kinase inhibitors useful for the treatment of myleoprolific diseases and other proliferative diseases	Patent 8143293 was granted and assigned to Deciphera Pharmaceuticals on March, 2012 by the United States Patent and Trademark Office.		Deciphera Pharmaceuticals	United States Patent and Trademark Office	8143293	March 27, 2012
‌ US Patent 7897762 Kinase inhibitors useful for the treatment of proliferative diseases	Patent 7897762 was granted and assigned to Deciphera Pharmaceuticals on March, 2011 by the United States Patent and Trademark Office.		Deciphera Pharmaceuticals	United States Patent and Trademark Office	7897762	March 1, 2011
‌ US Patent 11779572 Methods of treating gastrointestinal stromal tumors	Patent 11779572 was granted and assigned to Deciphera Pharmaceuticals on October, 2023 by the United States Patent and Trademark Office.	Deciphera Pharmaceuticals	Deciphera Pharmaceuticals	United States Patent and Trademark Office	11779572	October 10, 2023
‌ US Patent 8163756 Enzyme modulators and treatments	Patent 8163756 was granted and assigned to Deciphera Pharmaceuticals on April, 2012 by the United States Patent and Trademark Office.		Deciphera Pharmaceuticals	United States Patent and Trademark Office	8163756	April 24, 2012
‌ US Patent 11801237 Amorphous kinase inhibitor formulations and methods of use thereof	Patent 11801237 was granted and assigned to Deciphera Pharmaceuticals on October, 2023 by the United States Patent and Trademark Office.	Deciphera Pharmaceuticals	Deciphera Pharmaceuticals	United States Patent and Trademark Office	11801237	October 31, 2023
‌ US Patent 11344536 Methods of treating gastrointestinal stromal tumors	Patent 11344536 was granted and assigned to Deciphera Pharmaceuticals on May, 2022 by the United States Patent and Trademark Office.	Deciphera Pharmaceuticals	Deciphera Pharmaceuticals	United States Patent and Trademark Office	11344536	May 31, 2022
‌ US Patent 11679110 Methods of treating disorders using CSF1R inhibitors	Patent 11679110 was granted and assigned to Deciphera Pharmaceuticals on June, 2023 by the United States Patent and Trademark Office.	Deciphera Pharmaceuticals	Deciphera Pharmaceuticals	United States Patent and Trademark Office	11679110	June 20, 2023
‌ US Patent 9334267 RAF inhibitor compounds	Patent 9334267 was granted and assigned to Deciphera Pharmaceuticals on May, 2016 by the United States Patent and Trademark Office.		Deciphera Pharmaceuticals	United States Patent and Trademark Office	9334267	May 10, 2016
‌ US Patent 7790756 Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases	Patent 7790756 was granted and assigned to Deciphera Pharmaceuticals on September, 2010 by the United States Patent and Trademark Office.		Deciphera Pharmaceuticals	United States Patent and Trademark Office	7790756	September 7, 2010
‌ US Patent 9457019 Methods for inhibiting tie-2 kinase useful in the treatment of cancer	Patent 9457019 was granted and assigned to Deciphera Pharmaceuticals on October, 2016 by the United States Patent and Trademark Office.	Deciphera Pharmaceuticals	Deciphera Pharmaceuticals	United States Patent and Trademark Office	9457019	October 4, 2016
‌ US Patent 11529336 Methods of treating gastrointestinal stromal tumors	Patent 11529336 was granted and assigned to Deciphera Pharmaceuticals on December, 2022 by the United States Patent and Trademark Office.	Deciphera Pharmaceuticals	Deciphera Pharmaceuticals	United States Patent and Trademark Office	11529336	December 20, 2022
‌ US Patent 11576904 Methods of treating gastrointestinal stromal tumors	Patent 11576904 was granted and assigned to Deciphera Pharmaceuticals on February, 2023 by the United States Patent and Trademark Office.	Deciphera Pharmaceuticals	Deciphera Pharmaceuticals	United States Patent and Trademark Office	11576904	February 14, 2023
‌ US Patent 8940756 Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases	Patent 8940756 was granted and assigned to Deciphera Pharmaceuticals on January, 2015 by the United States Patent and Trademark Office.	Deciphera Pharmaceuticals	Deciphera Pharmaceuticals	United States Patent and Trademark Office	8940756	January 27, 2015
‌ US Patent 11426390 Methods of treating gastrointestinal stromal tumors	Patent 11426390 was granted and assigned to Deciphera Pharmaceuticals on August, 2022 by the United States Patent and Trademark Office.	Deciphera Pharmaceuticals	Deciphera Pharmaceuticals	United States Patent and Trademark Office	11426390	August 30, 2022
‌ US Patent 11433056 Methods of treating gastrointestinal stromal tumors	Patent 11433056 was granted and assigned to Deciphera Pharmaceuticals on September, 2022 by the United States Patent and Trademark Office.	Deciphera Pharmaceuticals	Deciphera Pharmaceuticals	United States Patent and Trademark Office	11433056	September 6, 2022
‌ US Patent 8461179 Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases	Patent 8461179 was granted and assigned to Deciphera Pharmaceuticals on June, 2013 by the United States Patent and Trademark Office.		Deciphera Pharmaceuticals	United States Patent and Trademark Office	8461179	June 11, 2013
‌ US Patent 11534432 Methods of treating gastrointestinal stromal tumors	Patent 11534432 was granted and assigned to Deciphera Pharmaceuticals on December, 2022 by the United States Patent and Trademark Office.	Deciphera Pharmaceuticals	Deciphera Pharmaceuticals	United States Patent and Trademark Office	11534432	December 27, 2022
‌ US Patent 11266635 Methods of treating gastrointestinal stromal tumors	Patent 11266635 was granted and assigned to Deciphera Pharmaceuticals on March, 2022 by the United States Patent and Trademark Office.	Deciphera Pharmaceuticals	Deciphera Pharmaceuticals	United States Patent and Trademark Office	11266635	March 8, 2022
‌ US Patent 7666895 Anti-inflammatory medicaments	Patent 7666895 was granted and assigned to Deciphera Pharmaceuticals on February, 2010 by the United States Patent and Trademark Office.		Deciphera Pharmaceuticals	United States Patent and Trademark Office	7666895	February 23, 2010
‌ US Patent 7531566 Anti-inflammatory medicaments	Patent 7531566 was granted and assigned to Deciphera Pharmaceuticals on May, 2009 by the United States Patent and Trademark Office.		Deciphera Pharmaceuticals	United States Patent and Trademark Office	7531566	May 12, 2009
‌ US Patent 7144911 Anti-inflammatory medicaments	Patent 7144911 was granted and assigned to Deciphera Pharmaceuticals on December, 2006 by the United States Patent and Trademark Office.		Deciphera Pharmaceuticals	United States Patent and Trademark Office	7144911	December 5, 2006
‌ US Patent 7202257 Anti-inflammatory medicaments	Patent 7202257 was granted and assigned to Deciphera Pharmaceuticals on April, 2007 by the United States Patent and Trademark Office.		Deciphera Pharmaceuticals	United States Patent and Trademark Office	7202257	April 10, 2007
‌ US Patent 7279576 Anti-cancer medicaments	Patent 7279576 was granted and assigned to Deciphera Pharmaceuticals on October, 2007 by the United States Patent and Trademark Office.		Deciphera Pharmaceuticals	United States Patent and Trademark Office	7279576	October 9, 2007

Results per page:

64 results

0 selected

64 results

0 selected